Order Article Reprints

Becciolini A, Parisi S, Caccavale R, Bravi E, Lumetti F, Andracco R, Volpe A, Gardelli L, Girelli F, Di Donato E, et al. Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis. Journal of Personalized Medicine. 2022; 12(3):335. https://doi.org/10.3390/jpm12030335

Becciolini, Andrea, Simone Parisi, Rosalba Caccavale, Elena Bravi, Federica Lumetti, Romina Andracco, Alessandro Volpe, Lucia Gardelli, Francesco Girelli, Eleonora Di Donato, and et al. 2022. "Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis" Journal of Personalized Medicine 12, no. 3: 335. https://doi.org/10.3390/jpm12030335

Becciolini, A., Parisi, S., Caccavale, R., Bravi, E., Lumetti, F., Andracco, R., Volpe, A., Gardelli, L., Girelli, F., Di Donato, E., Santilli, D., Lucchini, G., Ditto, M. C., Platè, I., Arrigoni, E., Mozzani, F., Riva, M., Marchetta, A., Fusaro, E., ... Ariani, A. (2022). Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis. Journal of Personalized Medicine, 12(3), 335. https://doi.org/10.3390/jpm12030335